R Silber

5.1k total citations · 1 hit paper
69 papers, 4.2k citations indexed

About

R Silber is a scholar working on Genetics, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, R Silber has authored 69 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Genetics, 22 papers in Molecular Biology and 15 papers in Public Health, Environmental and Occupational Health. Recurrent topics in R Silber's work include Chronic Lymphocytic Leukemia Research (27 papers), Acute Lymphoblastic Leukemia research (13 papers) and Lymphoma Diagnosis and Treatment (9 papers). R Silber is often cited by papers focused on Chronic Lymphocytic Leukemia Research (27 papers), Acute Lymphoblastic Leukemia research (13 papers) and Lymphoma Diagnosis and Treatment (9 papers). R Silber collaborates with scholars based in United States, Switzerland and France. R Silber's co-authors include M Potmĕsil, M. Edward Medof, Victor Nussenzweig, M G Low, Sanna M. Goyert, Alain Haziot, Elisabetta Ferrero, Taroh Kinoshita, Maryrose J. Conklyn and Franco Quagliata and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

R Silber

68 papers receiving 3.9k citations

Hit Papers

The monocyte differentiat... 1988 2026 2000 2013 1988 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
R Silber 1.7k 1.5k 873 798 461 69 4.2k
Howard B. Cottam 2.1k 1.3× 1.5k 1.1× 638 0.7× 594 0.7× 262 0.6× 123 5.1k
Suren N. Sehgal 2.6k 1.5× 858 0.6× 186 0.2× 713 0.9× 276 0.6× 58 5.5k
Paul Brennan 2.8k 1.7× 1.6k 1.1× 672 0.8× 1.0k 1.3× 481 1.0× 95 5.5k
BB Lozzio 2.3k 1.4× 1.2k 0.8× 780 0.9× 891 1.1× 199 0.4× 12 4.6k
CB Lozzio 2.3k 1.4× 1.2k 0.8× 781 0.9× 889 1.1× 200 0.4× 10 4.6k
D Santoli 1.9k 1.2× 3.5k 2.4× 309 0.4× 1.3k 1.7× 328 0.7× 111 6.6k
Bernard Sordat 2.3k 1.4× 1.6k 1.1× 217 0.2× 1.7k 2.1× 340 0.7× 111 5.7k
Lorenzo M. Leoni 1.8k 1.1× 758 0.5× 786 0.9× 817 1.0× 480 1.0× 57 3.7k
Laurent Genestier 2.0k 1.2× 1.9k 1.3× 218 0.2× 635 0.8× 260 0.6× 64 4.6k
K. Mark Coggeshall 3.6k 2.2× 3.9k 2.6× 445 0.5× 919 1.2× 209 0.5× 110 7.3k

Countries citing papers authored by R Silber

Since Specialization
Citations

This map shows the geographic impact of R Silber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Silber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Silber more than expected).

Fields of papers citing papers by R Silber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Silber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Silber. The network helps show where R Silber may publish in the future.

Co-authorship network of co-authors of R Silber

This figure shows the co-authorship network connecting the top 25 collaborators of R Silber. A scholar is included among the top collaborators of R Silber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Silber. R Silber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Levesque, Marc C., et al.. (2003). IL-4 and interferon gamma regulate expression of inducible nitric oxide synthase in chronic lymphocytic leukemia cells. Leukemia. 17(2). 442–450. 35 indexed citations
2.
Weinberg, JB, et al.. (2001). Nitric oxide enhancement of fludarabine cytotoxicity for B-CLL lymphocytes. Leukemia. 15(12). 1852–1859. 16 indexed citations
5.
Whitlow, M B, Kei Iida, Patricia Marshall, R Silber, & Victor Nussenzweig. (1993). Cells lacking glycan phosphatidylinositol-linked proteins have impaired ability to vesiculate. Blood. 81(2). 510–516. 35 indexed citations
7.
Golomb, Harvey M., A Fefer, David W. Golde, et al.. (1991). Survival Experience of 195 Patients with Hairy Cell Leukemia Treated in a Multi-Institutional Study with Interferon-Alfa 2B. Leukemia & lymphoma. 4(2). 99–102. 10 indexed citations
8.
Baumgartner, Walter, et al.. (1990). Bacteriological studies on sows with puerperal mastitis (MMA syndrome) on various farms in Austria.. Tierärztliche Umschau. 45(8). 526–535. 2 indexed citations
9.
Silber, R, et al.. (1990). Properties of haemolytic Escherichia coli strains from dogs and cats affected by, or dead from diarrhoea or enteritis. Virulence factors and sensitivity to antibiotics.. Wiener Tierarztliche Monatsschrift. 77(8). 254–258. 1 indexed citations
10.
Bank, Bruce, et al.. (1989). Chlorambucil pharmacokinetics and DNA binding in chronic lymphocytic leukemia lymphocytes.. PubMed. 49(3). 554–9. 48 indexed citations
11.
Golomb, Harvey M., Mark J. Ratain, A Fefer, et al.. (1988). Randomized Study of the Duration of Treatment With Interferon Alfa-2B in Patients With Hairy Cell Leukemia. JNCI Journal of the National Cancer Institute. 80(5). 369–373. 48 indexed citations
12.
Golomb, Harvey M., A Fefer, David W. Golde, et al.. (1988). Report of a multi-institutional study of 193 patients with hairy cell leukemia treated with interferon-alfa2b.. PubMed. 15(5 Suppl 5). 7–9. 38 indexed citations
13.
Selvaraj, Periasamy, Michael L. Dustin, R Silber, M G Low, & Timothy A. Springer. (1987). Deficiency of lymphocyte function-associated antigen 3 (LFA-3) in paroxysmal nocturnal hemoglobinuria. Functional correlates and evidence for a phosphatidylinositol membrane anchor.. The Journal of Experimental Medicine. 166(4). 1011–1025. 114 indexed citations
14.
Silber, R, Leroy F. Liu, Mervyn Israel, et al.. (1987). Metabolic activation of N-acylanthracyclines precedes their interaction with DNA topoisomerase II.. PubMed. 111–5. 11 indexed citations
15.
Kinoshita, Taroh, M. Edward Medof, R Silber, & Victor Nussenzweig. (1985). Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria.. The Journal of Experimental Medicine. 162(1). 75–92. 357 indexed citations
16.
Scher, Nancy S., et al.. (1976). Cyclic adenosine 3':5'-monophosphate phosphodiesterase activity in normal and chronic lymphocytic leukemia lymphocytes.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 36(11 Pt 1). 3958–62. 8 indexed citations
17.
Fleit, Howard B., et al.. (1975). Function of 5'-nucleotidase in the uptake of adenosine from AMP by human lymphocytes. Journal of Biological Chemistry. 250(23). 8889–8892. 90 indexed citations
18.
Silber, R, et al.. (1975). Human lymphocytes: 5'-nucleotidase-positive and -negative subpopulations.. Journal of Clinical Investigation. 56(5). 1324–1327. 50 indexed citations
19.
Quagliata, Franco, et al.. (1974). Studies on the lymphocyte 5'-nucleotidase in chronic lymphocytic leukemia, infectious mononucleosis, normal subpopulations, and phytohemagglutinin-stimulated cells.. PubMed. 34(12). 3197–202. 118 indexed citations
20.
Bertino, Joseph R., Dennis M. Donohue, Barbara S. Simmons, et al.. (1963). THE “INDUCTION” OF DIHYDROFOLIC REDUCTASE ACTIVITY IN LEUKOCYTES AND ERYTHROCYTES OF PATIENTS TREATED WITH AMETHOPTERIN*. Journal of Clinical Investigation. 42(4). 466–475. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026